How long does it take for new pharmaceuticals to reach low and middle-income countries?
That is the question considered by Wouters and Kuha (2024) in a recent Health Affairs article. The authors use IQVIA data between 1982 and 2024 on the timing of drug launches and estimate median delay times using a Kaplan Meier estimates. They find that: From the first launch globally, the median time to availability was…